Pharm3r's trusted platform and adherence to a proven process generates risk vectors, reports and reveals insights to help clients anticipate what’s next with confidence and precision. All while being flexible and highly customizable.
We curate data from reliable, authoritative life science sources. Our evidence engine continually updates, verifies, and normalizes every byte of traceable data. Throughout the process, our team of researchers and business analysts performs quality control checks, monitors the industry for mergers and acquisitions, litigation cases, and adverse events.
Over 80,000 Worldwide
NDA, ANDA, BLA Complete Coverage
Drug Labels OTC & Rx Complete Coverage
NDC Products & Packages Complete Coverage
FAERS over 13.6 Million Cases
Over 93,000 with complete coverage of:
Warning Letters
Recalls
Inspections, Citations, Form 483
Import Refusals
Over 454.000
510(k) Complete Coverage
PMA Complete Coverage
MAUDE over 13.5 Million Reports
UMLS
RxNorm
MedDRA
ATC
PubMed
Our advanced data science, real-time 360º view of the life science landscape, and tailored outcomes are part of our priority data aggregation platform with access to tools like Pandora. A platform that makes Pharm3r a leader in post-market surveillance of drugs, medical devices, patient outcomes and competitive analysis.
Unfortunately, good people given bad data make bad decisions. That’s why Pharm3r’s most valuable output for helping clients plan for the future is our renowned Risk Scores. These concise, at-a-glance assessments allow for easy comparisons of manufacturers, products, and facilities—including natural disaster risk indices—backed by the traceability of our evidence engine.